Scotiabank started coverage on shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) in a research report sent to investors on Wednesday, MarketBeat.com reports. The firm issued a sector ...
Some results have been hidden because they may be inaccessible to you